Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.
Science.
2006 Aug 25;313(5790):1137-40. doi: 10.1126/science.1128294. PubMed PMID:
16931765; PubMed Central PMCID:
PMC4741373.
Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.
Mol Cell.
2008 Mar 14;29(5):541-51. doi: 10.1016/j.molcel.2007.12.023. PubMed PMID:
18342602; PubMed Central PMCID:
PMC2361721.
Endoplasmic reticulum stress plays a central role in development of leptin resistance.
Cell Metab.
2009 Jan 7;9(1):35-51. doi: 10.1016/j.cmet.2008.12.004. PubMed PMID:
19117545; NIHMSID:NIHMS278674.
Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways.
J Clin Invest.
2009 Oct;119(10):2925-41. doi: 10.1172/JCI38857. Epub 2009 Sep 8. PubMed PMID:
19741297; PubMed Central PMCID:
PMC2752072.
Pivotal role of calcium/calmodulin-dependent protein kinase II in ER stress-induced apoptosis.
Cell Cycle.
2010 Jan 15;9(2):223-4. doi: 10.4161/cc.9.2.10596. Epub 2010 Jan 10. PubMed PMID:
20023415; PubMed Central PMCID:
PMC2846633.
NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis.
J Cell Biol.
2010 Dec 13;191(6):1113-25. doi: 10.1083/jcb.201006121. Epub 2010 Dec 6. PubMed PMID:
21135141; PubMed Central PMCID:
PMC3002036.
Role of endoplasmic reticulum stress in metabolic disease and other disorders.
Annu Rev Med.
2012;63:317-28. doi: 10.1146/annurev-med-043010-144749. Review. PubMed PMID:
22248326; PubMed Central PMCID:
PMC3290993.
Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.
Cell Metab.
2012 May 2;15(5):739-51. doi: 10.1016/j.cmet.2012.03.002. Epub 2012 Apr 12. PubMed PMID:
22503562; PubMed Central PMCID:
PMC3348356.
Endoplasmic reticulum stress in cardiometabolic disorders.
Curr Atheroscler Rep.
2012 Oct;14(5):469-75. doi: 10.1007/s11883-012-0270-z. Review. PubMed PMID:
22847769.
Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling.
Cell Metab.
2013 Dec 3;18(6):803-15. doi: 10.1016/j.cmet.2013.10.011. Epub 2013 Nov 21. PubMed PMID:
24268736; PubMed Central PMCID:
PMC3863383.
CaMKII in cardiometabolic disease.
Aging (Albany NY).
2014 Jun;6(6):430-1. doi: 10.18632/aging.100675. PubMed PMID:
25011473; PubMed Central PMCID:
PMC4100805.
Common therapeutic targets in cardiometabolic disease.
Sci Transl Med.
2014 Jun 4;6(239):239ps5. doi: 10.1126/scitranslmed.3008908. Review. PubMed PMID:
24898746; PubMed Central PMCID:
PMC4176709.
Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.
Proc Natl Acad Sci U S A.
2014 Oct 7;111(40):14530-5. doi: 10.1073/pnas.1410851111. Epub 2014 Sep 22. PubMed PMID:
25246560; PubMed Central PMCID:
PMC4210018.
Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity.
PLoS One.
2015;10(8):e0135842. doi: 10.1371/journal.pone.0135842. eCollection 2015. PubMed PMID:
26317499; PubMed Central PMCID:
PMC4552860.
Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity.
Diabetes.
2015 Oct;64(10):3396-405. doi: 10.2337/db14-1945. Epub 2015 Jun 11. PubMed PMID:
26068544; PubMed Central PMCID:
PMC4587644.
Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance.
Cell Rep.
2016 Jun 7;15(10):2214-2225. doi: 10.1016/j.celrep.2016.05.006. Epub 2016 May 26. PubMed PMID:
27239042; PubMed Central PMCID:
PMC5068925.
CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
J Clin Invest.
2017 Nov 1;127(11):4075-4089. doi: 10.1172/JCI94735. Epub 2017 Oct 3. PubMed PMID:
28972541; PubMed Central PMCID:
PMC5663361.
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Gastroenterology.
2017 Dec;153(6):1568-1580.e10. doi: 10.1053/j.gastro.2017.08.039. Epub 2017 Aug 30. PubMed PMID:
28859855; PubMed Central PMCID:
PMC5705280.
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
Nature.
2018 Mar 29;555(7698):673-677. doi: 10.1038/nature26138. Epub 2018 Mar 21. PubMed PMID:
29562231; PubMed Central PMCID:
PMC6021131.
A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose.
Cell Rep.
2018 Jul 10;24(2):312-319. doi: 10.1016/j.celrep.2018.06.039. PubMed PMID:
29996093; PubMed Central PMCID:
PMC6086569.
A New Activator of Hepatocyte CaMKII in Fasting and Type 2 Diabetes.
Diabetes.
2018 Sep;67(9):1742-1744. doi: 10.2337/dbi18-0026. PubMed PMID:
30135135; PubMed Central PMCID:
PMC6905480.
Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol.
Circ Res.
2019 Jan 4;124(1):38-51. doi: 10.1161/CIRCRESAHA.118.313648. PubMed PMID:
30582457; PubMed Central PMCID:
PMC6457439.
An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1.
Blood.
2019 Feb 14;133(7):743-753. doi: 10.1182/blood-2018-07-864843. Epub 2018 Dec 1. PubMed PMID:
30504459; PubMed Central PMCID:
PMC6376283.
Proprotein convertase subtilisin/kexin type 9 and lipid metabolism.
Curr Opin Lipidol.
2019 Jun;30(3):186-191. doi: 10.1097/MOL.0000000000000601. Review. PubMed PMID:
30925519; PubMed Central PMCID:
PMC6824479.
Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity.
J Clin Invest.
2020 Aug 3;130(8):4348-4359. doi: 10.1172/JCI135919. PubMed PMID:
32657780; PubMed Central PMCID:
PMC7410057.
Targeting Soluble DPP-4 for Insulin Resistance: Origin Matters.
J Clin Endocrinol Metab.
2021 Mar 8;106(3):e1460-e1462. doi: 10.1210/clinem/dgaa902. PubMed PMID:
33274386; PubMed Central PMCID:
PMC7947836.
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis.
PLoS One.
2021;16(5):e0246600. doi: 10.1371/journal.pone.0246600. eCollection 2021. PubMed PMID:
33983975; PubMed Central PMCID:
PMC8118275.
Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance.
Mol Metab.
2021 Nov;53:101300. doi: 10.1016/j.molmet.2021.101300. Epub 2021 Jul 22. PubMed PMID:
34303021; PubMed Central PMCID:
PMC8365526.
Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia.
Cell Rep.
2022 Aug 23;40(8):111259. doi: 10.1016/j.celrep.2022.111259. PubMed PMID:
36001955; PubMed Central PMCID:
PMC9446800.
What would you like to do?